Aldana I - Search Results

1

Synthesis and evaluation of new arylsulfonamidomethylcyclohexyl derivatives as human neuropeptide Y Y5 receptor antagonists for the treatment of obesity.

Moreno A, Pérez S, Galiano S, Juanenea L, Erviti O, Frígola C, Aldana I, Monge A. Moreno A, et al. Among authors: aldana i. Eur J Med Chem. 2004 Jan;39(1):49-58. doi: 10.1016/j.ejmech.2003.10.001. Eur J Med Chem. 2004. PMID: 14987833

2

Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.

Zarranz B, Jaso A, Aldana I, Monge A. Zarranz B, et al. Among authors: aldana i. Bioorg Med Chem. 2003 May 15;11(10):2149-56. doi: 10.1016/s0968-0896(03)00119-6. Bioorg Med Chem. 2003. PMID: 12713824

3

Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.

Jaso A, Zarranz B, Aldana I, Monge A. Jaso A, et al. Among authors: aldana i. Eur J Med Chem. 2003 Sep;38(9):791-800. doi: 10.1016/s0223-5234(03)00137-5. Eur J Med Chem. 2003. PMID: 14561478

4

Synthesis of new thiophene and benzo[b]thiophene hydrazide derivatives as human NPY Y(5) antagonists.

Galiano S, Erviti O, Pérez S, Moreno A, Juanenea L, Aldana I, Monge A. Galiano S, et al. Among authors: aldana i. Bioorg Med Chem Lett. 2004 Feb 9;14(3):597-9. doi: 10.1016/j.bmcl.2003.11.070. Bioorg Med Chem Lett. 2004. PMID: 14741250

5

Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.

Zarranz B, Jaso A, Aldana I, Monge A. Zarranz B, et al. Among authors: aldana i. Bioorg Med Chem. 2004 Jul 1;12(13):3711-21. doi: 10.1016/j.bmc.2004.04.013. Bioorg Med Chem. 2004. PMID: 15186857

6

Synthesis and evaluation of new hydrazide derivatives as neuropeptide Y Y5 receptor antagonists for the treatment of obesity.

Juanenea L, Galiano S, Erviti O, Moreno A, Pérez S, Aldana I, Monge A. Juanenea L, et al. Among authors: aldana i. Bioorg Med Chem. 2004 Sep 1;12(17):4717-23. doi: 10.1016/j.bmc.2004.06.023. Bioorg Med Chem. 2004. PMID: 15358298

7

Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.

Jaso A, Zarranz B, Aldana I, Monge A. Jaso A, et al. Among authors: aldana i. J Med Chem. 2005 Mar 24;48(6):2019-25. doi: 10.1021/jm049952w. J Med Chem. 2005. PMID: 15771444

8

Novel human neuropeptide Y Y5 receptor antagonists for the treatment of obesity. Synthesis and biological evaluation of pyridine hydrazide derivatives.

Galiano S, Erviti O, Pérez S, Moreno A, Juanenea L, Aldana I, Monge A. Galiano S, et al. Among authors: aldana i. Arzneimittelforschung. 2005;55(2):81-5. doi: 10.1055/s-0031-1296827. Arzneimittelforschung. 2005. PMID: 15787274

9

Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity.

Galiano S, Ceras J, Cirauqui N, Pérez S, Juanenea L, Rivera G, Aldana I, Monge A. Galiano S, et al. Among authors: aldana i. Bioorg Med Chem. 2007 Jun 1;15(11):3896-911. doi: 10.1016/j.bmc.2007.02.049. Epub 2007 Mar 3. Bioorg Med Chem. 2007. PMID: 17407817

10

Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analogues.

Solano B, Junnotula V, Marín A, Villar R, Burguete A, Vicente E, Pérez-Silanes S, Aldana I, Monge A, Dutta S, Sarkar U, Gates KS. Solano B, et al. Among authors: aldana i. J Med Chem. 2007 Nov 1;50(22):5485-92. doi: 10.1021/jm0703993. Epub 2007 Oct 2. J Med Chem. 2007. PMID: 17910426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters